找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Quality Management and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy; The JACIE Guide Mahmoud Aljurf,John A

[復(fù)制鏈接]
樓主: 小費(fèi)
31#
發(fā)表于 2025-3-26 23:46:03 | 只看該作者
32#
發(fā)表于 2025-3-27 01:35:02 | 只看該作者
Personnel Requirements Including Job Descriptions,ous development of their competencies. Job descriptions for personnel should not be limiting and should support continuous professional development. In addition, accurate and frequent communication will increase cooperation within cellular therapy centres, minimise margins of error and contribute positively to patient care.
33#
發(fā)表于 2025-3-27 06:01:16 | 只看該作者
34#
發(fā)表于 2025-3-27 11:41:10 | 只看該作者
Tracking and Traceability,ogether will form an ‘information environment’. Together with electronic standards such as ISBT128 and Eurocode, this will further enhance safety, accuracy and efficiency in tracking and tracing cellular products.
35#
發(fā)表于 2025-3-27 14:54:01 | 只看該作者
Training Programme,rocedures as well as cooperate with personnel from other disciplines. Staff training plays a key role in the implementation of cell therapy and in QM. New cell therapy applications are constantly being developed. Appropriate training of personnel will improve both the effectiveness of cell therapy and patient survival.
36#
發(fā)表于 2025-3-27 17:52:12 | 只看該作者
Quality and Standards for Haematopoietic Stem Cells Transplantation Programs,transplantation professionals have been continuously developing and improving standards to help control this complexity and manage the inherent risks of this treatment. In this regard, HSCT was, and continues to be, a pioneer in the area of quality and standards.
37#
發(fā)表于 2025-3-28 01:17:19 | 只看該作者
38#
發(fā)表于 2025-3-28 04:38:39 | 只看該作者
Adverse Events and Corrective and Preventive Actions, in this case, the transplant programme quality system should have specific SOP that includes a system to manage any issues, actions to prevent adverse events and deviations, and a description of the step to resolve them.
39#
發(fā)表于 2025-3-28 10:02:56 | 只看該作者
Risk Management,by whom, why, how, and when this approach should be applied in order to benefit the production and use of safe and effective cell-based therapies in general and hematopoietic stem cell transplantation in particular.
40#
發(fā)表于 2025-3-28 13:49:37 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 17:22
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
广平县| 尤溪县| 临清市| 武穴市| 兴文县| 井陉县| 南郑县| 双鸭山市| 宝坻区| 青神县| 宣化县| 东莞市| 吉林市| 河北省| 交口县| 玉龙| 登封市| 承德市| 洪雅县| 仁寿县| 德江县| 恩平市| 民勤县| 彩票| 凉城县| 沂南县| 彭山县| 塔城市| 博客| 云南省| 哈尔滨市| 化德县| 达尔| 萨嘎县| 曲水县| 太和县| 广昌县| 蓝山县| 东至县| 中宁县| 沐川县|